CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home Afenemi (Sodium hyaluronate, artificial tear, free preservative, sigle dose, for dry eye symtomp)
News
25 Oct 2025

Afenemi (Sodium hyaluronate, artificial tear, free preservative, sigle dose, for dry eye symtomp)

Afenemi (Sodium hyaluronate, artificial tear, free preservative, sigle dose, for dry eye symtomp)Lubricate for eye. Relief of dry eyes and eye irritation associated with deficient tear production.

Composition

Sodium hyaluronate 1.8 mg/ml.

Dosage Form
Single-dose ophthalmic

Indication
Lubricate for eye

Relief of dry eyes and eye irritation associated with deficient tear production.

Dosage Administration


Twist off tab. Tilt the head backwards and position the tip of the container above the eye to be treated. Move the lower eyelid down with the forefinger of one hand. Press the container and one drop of AFENEMI will easily flow out. If not otherwise recommended, instill 1 or 2 drops of AFENEMI onto the eye as often as needed. After blinking, the solution will disperse and form a transparent and long-lasting coating on the surface of the eye. AFENEMI may also be used while wearing contact lenses (rigid or soft).
 

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile
Related categories
Contract Manufacturing of Dosage Form Drugs Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)